CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$3.61
-0.11 (-2.96%)
As of Nov 7, 10:02 PM ET ·
Financial Highlights (FY 2026)
Revenue
197.82M
Net Income
-12,729,451
Gross Margin
43.3%
Profit Margin
-6.4%
Rev Growth
+16.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.3% 43.3% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 197.82M 169.31M 608.59M 622.30M
Gross Profit 85.58M 73.24M 334.31M 341.84M
Operating Income -23,481,703 -18,087,583 88.72M 91.23M
Net Income -12,729,451 -9,805,294 77.66M 87.35M
Gross Margin 43.3% 43.3% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Rev Growth +16.8% +16.8% +15.9% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 544.31M 499.08M
Total Equity — — 682.78M 653.80M
D/E Ratio — — 0.80 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -20,594,803 -16,745,175 120.12M 125.66M
Free Cash Flow — — 67.66M 69.93M